- This topic has 3 replies, 4 voices, and was last updated 3 years, 8 months ago by
.
-
Posts
-
-
Director of Multichannel Content for Pulmonary Fibrosis News, Michael Morale, discusses a study that shows that a low BMI may be a risk factor for gastrointestinal side effects in IPF patients on Ofev.
Are you interested in learning more about Pulmonary Fibrosis? If so, please visit pulmonaryfibrosisnews.com/
What are your thoughts about this news?
-
-
Great. IPF has reduced my appetite and food consumption, and consequently caused significant weight loss and lower BMI. It is a vicious circle. Taking famotidine, the generic Pepsid AC, has helped with acid reflux and increased my appetite somewhat. I am taking 100 Mg OFEV twice a day along with 801 mg Esbriet three times daily.
-
Hello Robert and Jim, I really don’t like the word “might” in the title. Gastro problems can affect all BMI types. Until a definitive study comes it is basically a 50/50 chance you might have a problem. I experienced several bouts of gastric problems while taking ofev and I by no means had or have a low BMI. Thank you both for commenting. Please review the topics on ofev in our forum. Everyone had their own way of eating to avoid these type of problems. Mark
-
-
- You must be logged in to reply to this topic.
